Back to Results
First PageMeta Content
Cowen Group / Research / Cowen / Clinical trial / Riedel / Pharmaceutical sciences / Drug discovery / Science / Antidepressant


Naurex to Present at Cowen and Co. 34th Annual Health Care Conference EVANSTON, Ill. – Feb. 27, 2014 – Naurex Inc. today announced that its president and chief executive officer, Norbert G. Riedel, Ph.D., will presen
Add to Reading List

Document Date: 2014-02-27 15:32:41

Open Document

File Size: 22,75 KB

Share Result on Facebook

City

EVANSTON / Boston / /

Company

Naurex Inc. / Cowen and Co. / /

Event

FDA Phase / /

IndustryTerm

therapy for major depressive disorder / clinical-stage biopharmaceutical company developing products / /

MedicalCondition

major depressive disorder / diseases / /

MedicalTreatment

adjunctive therapy / /

Person

Norbert G. Riedel / /

Position

president and chief executive officer / /

Product

34th Annual Health Care Conference EVANSTON / GLYX-13 / NRX-1074 / /

ProvinceOrState

Illinois / Massachusetts / /

URL

www.cowen.com/conferences/upcoming-conferences / www.naurex.com / /

SocialTag